Skip to content
Monday, December 2, 2024
Wall Street Insider
Deliver critical advise to busy investors
Search
Search
News
About Us
Services
Institutional Research
Portfolio Analysis
#1 Stock Pick
Subscriptions
Contact Us
CLIENT LOGIN
Home
News
23andMe to slash 40% of its workforce, end therapeutics program to cut costs
News
23andMe to slash 40% of its workforce, end therapeutics program to cut costs
November 12, 2024
Arthur Bleemer
DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as part of a restructuring effort to cut costs, the company said Monday.
Read more from source
Post navigation
My grandmother gave her neighbor $6,000 to buy a car. There was no car. How can I protect her from further exploitation?
Live Nation just had its most active summer concert season ever. And Shakira, Coldplay are coming in 2025.